81 related articles for article (PubMed ID: 15682073)
1. Effects of CD34
Oyama T; Fujiwara SI; Tominaga R; Yokoyama D; Noguchi A; Furuki S; Koyama S; Murahashi R; Nakashima H; Hyodo K; Ikeda T; Kawaguchi SI; Toda Y; Nagayama T; Umino K; Minakata D; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Otsuki I; Ohmine K; Kanda Y
Clin Transplant; 2024 Apr; 38(4):e15313. PubMed ID: 38581299
[TBL] [Abstract][Full Text] [Related]
2. A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Ishida H; Kawahara Y; Tomizawa D; Okamoto Y; Hama A; Cho Y; Koh K; Koga Y; Yoshida N; Sato M; Terui K; Miyagawa N; Watanabe A; Takita J; Kobayashi R; Yamamoto M; Watanabe K; Okada K; Kato K; Matsumoto K; Hino M; Tabuchi K; Sakaguchi H
J Hematol Oncol; 2024 Apr; 17(1):24. PubMed ID: 38679709
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional Plasticity Drives Leukemia Immune Escape.
Eagle K; Harada T; Kalfon J; Perez MW; Heshmati Y; Ewers J; Koren JV; Dempster JM; Kugener G; Paralkar VR; Lin CY; Dharia NV; Stegmaier K; Orkin SH; Pimkin M
Blood Cancer Discov; 2022 Sep; 3(5):394-409. PubMed ID: 35709529
[TBL] [Abstract][Full Text] [Related]
4. Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.
Mamo T; Sumstad D; DeFor TE; Cao Q; MacMillan ML; Brunstein C; Juckett M; McKenna DH
Transplant Cell Ther; 2023 Oct; 29(10):638.e1-638.e8. PubMed ID: 37419326
[TBL] [Abstract][Full Text] [Related]
5. Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34
Cao LQ; Xu LP; Zhang XH; Wang Y; Liu YR; Liu KY; Huang XJ; Chang YJ
Chin Med J (Engl); 2018 Sep; 131(18):2185-2192. PubMed ID: 30203793
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells in research and clinical applications: The "CD34 issue".
Ivanovic Z
World J Stem Cells; 2010 Apr; 2(2):18-23. PubMed ID: 21607112
[TBL] [Abstract][Full Text] [Related]
7. Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device.
Wojciechowski JC; Narasipura SD; Charles N; Mickelsen D; Rana K; Blair ML; King MR
Br J Haematol; 2008 Mar; 140(6):673-81. PubMed ID: 18218048
[TBL] [Abstract][Full Text] [Related]
8. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.
Clausen J; Wolf D; Petzer AL; Gunsilius E; Schumacher P; Kircher B; Gastl G; Nachbaur D
Clin Exp Immunol; 2007 Jun; 148(3):520-8. PubMed ID: 17493020
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
10. DC2 effect on survival following allogeneic bone marrow transplantation.
Waller EK; Rosenthal H; Sagar L
Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):19-26. PubMed ID: 11829279
[TBL] [Abstract][Full Text] [Related]
11. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
[TBL] [Abstract][Full Text] [Related]
12. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
Morariu-Zamfir R; Rocha V; Devergie A; Socié G; Ribaud P; Esperou H; Parquet N; Guardiola P; Dal Cortivo L; Bittencourt H; Garnier F; Traineau R; Marolleau JP; Chevret S; Gluckman E
Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
[TBL] [Abstract][Full Text] [Related]
13. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
14. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
